Emerging in the arena of obesity management, retatrutide represents a different approach. Beyond many existing medications, retatrutide functions as a double agonist, at once engaging both GLP-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors. This dual engagement fosters several helpful effects, such as better… Read More